SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES

Identification of Sandoz Dimethyl Fumarate Delayed-Release Capsules

No description

Google image searchProduct monograph

Active ingredient

dimethyl fumarate, 240 MG

DIN: 02513803

Dosage form(s): CAPSULE (DELAYED RELEASE)

Route(s) of administration: ORAL

Schedule: Prescription

Company: SANDOZ CANADA INCORPORATED

Date: 04-OCT-2021

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AX — Other immunosuppressants (ATC, ATC/DDD)
• L04AX07 — DIMETHYL FUMARATE (ATC/DDD)

Reference brand drug: Tecfidera

External Links for Sandoz Dimethyl Fumarate Delayed-Release Capsules

Search on Google

• Sandoz Dimethyl Fumarate Delayed-Release Capsules side effects
• Sandoz Dimethyl Fumarate Delayed-Release Capsules dosage
• dimethyl fumarate side effects
• dimethyl fumarate dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find sandoz dimethyl fumarate delayed-release capsules photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.